Henry Ford — Novi, Michigan

Public research footprint of Henry Ford, compiled from the ClinicalTrials.gov public registry.

263

Registered studies

154

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Lung Non-Squamous Non-Small Cell Carcinoma · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma

Recently updated registry entries

NCT04310007 — Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune… (Active Not Recruiting)
NCT03191149 — Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change (Recruiting)
NCT05554406 — Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Henry Ford?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.